Lead by Science –
The Panacea Difference
At Panacea Life, we are focused on creating research based, naturally derived products that improve the lives of patients suffering from seven categories of conditions: pain, neuroprotection, cancer, anxiety, sleep, metabolic, and autoimmune disorders.
Through our commitment to ongoing scientific research, we discover more every day about how health-supporting chemical compounds found in nature can be used to help the human body alleviate many acute and chronic conditions.
Our vision is to create a world where the human body can repair, restore and rejuvenate itself. Our mission is to do this by bringing phytocannabinoid based therapeutic products into the mainstream of healthcare.
Why Panacea Life Hemp Extract
Get back to living the life you want
Fast Absorbing Sublinguals
Sublingual tablets melt quickly under your tongue, allowing your body to absorb more of the cannabinoids and naturally occurring antioxidants of hemp oil.
Create a future where the human body can restore, rejuvenate and replenish itself
with rapid delivery hemp oil extract tablets.
Address everyday stress and bring your mind and body back into balance FAST with melt in your mouth tablets rich in phytocannabinoids.
- Contains 35 mg of naturally occurring phytocannabinoid rich hemp oil extract
- Sublingual pills dissolve under the tongue to enter your system quickly and deliver the maximum absorption of cannabinoids
- No added sugar or artificial ingredients
- Rich in antioxidants
- Naturally grown in the USA with no pesticides or herbicides
What are Phytocannabinoids?
Although phytocannabinoids have been utilized in ancient medicine for centuries, they have only gained notoriety for their pharmacological-level potential in the last decade. Over 1600 scientific articles have been published on their mechanism of action, and interest in researching the phytocannabinoid is likely to continue to grow exponentially.
Be the first to know
Get all the latest information on Events, Sales and Offers. Sign up for our newsletter today.